Top ten highlights from the APAC PE, VC, and startup ecosystem this week:
- **TikTok’s Market Threats**: The looming business ban on TikTok in the US is presenting opportunities for rivals such as YouTube and Meta as users and advertisers seek alternatives.
- **HQ Capital’s Expansion**: HQ Capital is looking to expand its fundraising and investment practices in Asia with a new regional head appointment.
- **Novo Holdings Focuses on Asia**: Novo Holdings is increasing its allocation for Asia to bolster its focus on the region’s life sciences investments.
- **Stonepeak’s Clean Energy Bet**: US infrastructure investor Stonepeak is betting on Asia Pacific’s energy transition for growth potential.
- **Trident Growth Partners in India**: Trident Growth Partners in India is raising funds for its debut growth-stage equity fund.
- **Partners Group’s Private Equity Fund**: Partners Group has launched a private equity secondary strategy fund to tap into growing deal flows.
- **TPG Inc’s China Allocation**: TPG Inc is reducing its China allocation by more than half from prior regional funds.
- **Private Equity Trends in Asia Pacific**: Private equity fundraising in Asia Pacific fell to a 10-year low in 2023 amid macroeconomic uncertainty.
- **Mubadala Investment in Avanse**: Abu Dhabi’s Mubadala Investment Company led a $120.6 million equity financing round in Indian educational loan provider Avanse Financial Services.
- **HSBC’s Debt Funds**: HSBC set aside $1.15 billion across two new debt funds focused on digitizing companies in Southeast Asia.
APAC Private Markets Research
Explore latest Insights on APAC Private Markets on Smartkarma
Disclaimer:This article by is general in nature and based on publicly available information and not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material. While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
Also, check out the latest in ECM Research on Smartkarma
